Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Sphincter of Oddi Dysfunction
NCT00471315Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jul 2006
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of duloxetine in sphincter of Oddi dysfunction (SOD), sponsored by Medical University of South Carolina. Primary endpoint: Patient Global Assessment of Change at 3 months. Started Jul 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
sphincter of Oddi dysfunction (SOD)
Beyond the preview
Go deeper on NCT00471315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471315.